2020 Q1 Form 10-K Financial Statement

#000121390020008003 Filed on March 30, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019
Revenue $198.8K $340.0K $2.985M
YoY Change -88.55% -84.96% -63.56%
Cost Of Revenue $152.8K $290.0K $2.307M
YoY Change -87.17% -86.45% -69.83%
Gross Profit $45.98K $50.00K $677.3K
YoY Change -91.55% -58.33% 24.8%
Gross Profit Margin 23.13% 14.71% 22.69%
Selling, General & Admin $800.0K $1.080M $2.029M
YoY Change 110.33% -43.16% -35.55%
% of Gross Profit 1739.85% 2160.0% 299.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $924.00 $40.00K $9.621K
YoY Change -70.81% -75.0% 42.24%
% of Gross Profit 2.01% 80.0% 1.42%
Operating Expenses $795.5K $1.080M $7.381M
YoY Change -23.13% -42.86% 36.97%
Operating Profit -$749.5K -$1.030M -$6.704M
YoY Change 52.73% -41.81% 38.34%
Interest Expense $2.811K -$180.0K -$180.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net $2.052K $10.00K -$216.5K
YoY Change -10208.68%
Pretax Income -$747.4K -$4.130M -$6.921M
YoY Change 52.31% 132.02% 42.87%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$747.4K -$4.130M -$6.921M
YoY Change 52.31% 125.68% 42.87%
Net Earnings / Revenue -376.05% -1214.71% -231.86%
Basic Earnings Per Share
Diluted Earnings Per Share -$641.0K -$8.787M -$23.07M
COMMON SHARES
Basic Shares Outstanding 1.171M shares 6.008M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $400.0K $1.630M $1.630M
YoY Change 60.0% 18.98% 18.98%
Cash & Equivalents $398.7K $1.626M $1.630M
Short-Term Investments
Other Short-Term Assets $17.50M $17.60M $70.00K
YoY Change -81.73% -81.99% -92.93%
Inventory $0.00
Prepaid Expenses
Receivables $1.095M $1.101M $1.210M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.651M $2.907M $2.910M
YoY Change -58.72% -33.36% -33.26%
LONG-TERM ASSETS
Property, Plant & Equipment $10.82K $11.75K $10.00K
YoY Change -84.12% -83.53% -85.71%
Goodwill $1.224M $1.224M
YoY Change -70.6% -70.6%
Intangibles $2.263M $2.299M
YoY Change -6.03% -5.94%
Long-Term Investments
YoY Change
Other Assets $180.0K $190.0K $190.0K
YoY Change
Total Long-Term Assets $4.085M $3.728M $3.720M
YoY Change -38.46% -44.17% -44.31%
TOTAL ASSETS
Total Short-Term Assets $1.651M $2.907M $2.910M
Total Long-Term Assets $4.085M $3.728M $3.720M
Total Assets $5.737M $6.635M $6.630M
YoY Change -46.08% -39.9% -39.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.750M $2.110M $2.110M
YoY Change -22.22% -19.47% -19.47%
Accrued Expenses
YoY Change
Deferred Revenue $137.2K $169.0K
YoY Change -91.32% -87.34%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.885M $2.274M $2.270M
YoY Change -50.8% -42.55% -42.68%
LONG-TERM LIABILITIES
Long-Term Debt $200.0K $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $200.0K $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.885M $2.274M $2.270M
Total Long-Term Liabilities $200.0K $0.00 $0.00
Total Liabilities $2.085M $2.274M $2.270M
YoY Change -45.55% -42.56% -42.68%
SHAREHOLDERS EQUITY
Retained Earnings -$18.33M -$17.58M
YoY Change 64.35% 64.9%
Common Stock $11.71K $11.58K
YoY Change -72.52% 443.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.651M $4.360M $4.360M
YoY Change
Total Liabilities & Shareholders Equity $5.737M $6.635M $6.630M
YoY Change -46.08% -39.9% -39.95%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019
OPERATING ACTIVITIES
Net Income -$747.4K -$4.130M -$6.921M
YoY Change 52.31% 125.68% 42.87%
Depreciation, Depletion And Amortization $924.00 $40.00K $9.621K
YoY Change -70.81% -75.0% 42.24%
Cash From Operating Activities -$1.027M -$320.0K -$2.816M
YoY Change -8.15% -79.22% -18.44%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $2.070K
YoY Change -100.0% -97.1%
Acquisitions
YoY Change
Other Investing Activities -$400.0K $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$400.0K $0.00 -$2.070K
YoY Change -95.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $199.9K 1.930M $3.075M
YoY Change
NET CHANGE
Cash From Operating Activities -$1.027M -320.0K -$2.816M
Cash From Investing Activities -$400.0K 0.000 -$2.070K
Cash From Financing Activities $199.9K 1.930M $3.075M
Net Change In Cash -$1.227M 1.610M $257.3K
YoY Change 9.75% -204.55% -107.35%
FREE CASH FLOW
Cash From Operating Activities -$1.027M -$320.0K -$2.816M
Capital Expenditures $0.00 $2.070K
Free Cash Flow -$1.027M -$320.0K -$2.818M
YoY Change -8.15% -79.08% -20.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213002 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001023994
CY2019 dei Trading Symbol
TradingSymbol
SGBX
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
396214 USD
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
106015 USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019 us-gaap Operating Loss Carryforwards Expiration Date
OperatingLossCarryforwardsExpirationDate
2037-12-31
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1157890 shares
CY2019 sgbx Description Of Claimed Amount
DescriptionOfClaimedAmount
Company and its Chairman and Chief Executive Officer, Paul Galvin, claiming (i) $372,638 in unpaid wages and bonuses and (ii) $300,000 due in severance (hereafter the “Action”).
CY2019 dei Entity Address Address Line2
EntityAddressAddressLine2
14th Floor,
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Entity File Number
EntityFileNumber
001-38037
CY2019 dei Entity Registrant Name
EntityRegistrantName
SG BLOCKS, INC.
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4463937
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
195 Montague Street,
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Brooklyn
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11201
CY2019 dei City Area Code
CityAreaCode
(646)
CY2019 dei Local Phone Number
LocalPhoneNumber
240-4235
CY2019 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 dei Entity Public Float
EntityPublicFloat
3597728 USD
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1170524 shares
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1625671 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1368395 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1746326 USD
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
260325 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
73938 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
986687 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
4361733 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11747 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71337 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1223520 USD
CY2018Q4 us-gaap Goodwill
Goodwill
4162173 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2298805 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2443929 USD
CY2019Q4 us-gaap Deferred Costs
DeferredCosts
193730 USD
CY2018Q4 us-gaap Deferred Costs
DeferredCosts
USD
CY2019Q4 us-gaap Assets
Assets
6634611 USD
CY2018Q4 us-gaap Assets
Assets
11039172 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2105505 USD
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2624218 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
168957 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1334887 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2274462 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3959105 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2019 us-gaap Other General Expense
OtherGeneralExpense
21286 USD
CY2018 us-gaap Other General Expense
OtherGeneralExpense
74629 USD
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5405010 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5405010 shares
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1157890 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213002 shares
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
11579 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
2130 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21932387 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17741214 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17583817 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10663277 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
4360149 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
7080067 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6634611 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11039172 USD
CY2019 us-gaap Revenues
Revenues
2984835 USD
CY2018 us-gaap Revenues
Revenues
8190712 USD
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
2307488 USD
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
7647979 USD
CY2019 us-gaap Gross Profit
GrossProfit
677347 USD
CY2018 us-gaap Gross Profit
GrossProfit
542733 USD
CY2019 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2392587 USD
CY2018 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2166212 USD
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1788276 USD
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2760655 USD
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
240557 USD
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
387400 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
7381359 USD
CY2018 us-gaap Operating Expenses
OperatingExpenses
5388896 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-6704012 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-4846163 USD
CY2019 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
178995 USD
CY2018 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
USD
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
USD
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
4 USD
CY2019 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
14506 USD
CY2018 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
5764 USD
CY2019 sgbx Loss Debt Conversion
LossDebtConversion
52039 USD
CY2018 sgbx Loss Debt Conversion
LossDebtConversion
USD
CY2019 sgbx Gain Loss From Equity Affiliaties
GainLossFromEquityAffiliaties
USD
CY2018 sgbx Gain Loss From Equity Affiliaties
GainLossFromEquityAffiliaties
-3626 USD
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-216528 USD
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2142 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6920540 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4844021 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
USD
CY2018 us-gaap Depreciation
Depreciation
6764 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
145124 USD
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
589619 USD
CY2019 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
10196 USD
CY2018 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
USD
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
105770 USD
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
USD
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
73225 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-6920540 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-4844021 USD
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
22.85
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-22.74
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
302844 shares
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
213002 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
5433295 USD
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
701402 USD
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8408 USD
CY2017 sgbx Stock Issued During Period Issuance Of Convertible Preferred Stock
StockIssuedDuringPeriodIssuanceOfConvertiblePreferredStock
USD
CY2017 sgbx Stock Issued During Period Issuance Of Common Stock Net Of Issuance Costs
StockIssuedDuringPeriodIssuanceOfCommonStockNetOfIssuanceCosts
7059615 USD
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
254500 USD
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2583334 USD
CY2017 us-gaap Profit Loss
ProfitLoss
-4512680 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
11527874 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
11527874 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-4844021 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
7080067 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
7080067 USD
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
946660 USD
CY2019 sgbx Stock Issued During Period Issuance Of Common Stock Net Of Issuance Costs
StockIssuedDuringPeriodIssuanceOfCommonStockNetOfIssuanceCosts
3253962 USD
CY2019 us-gaap Profit Loss
ProfitLoss
-6920540 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
4360149 USD
CY2019 us-gaap Profit Loss
ProfitLoss
-6920540 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-4844021 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2938653 USD
CY2019 us-gaap Depreciation
Depreciation
9621 USD
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-54000 USD
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
810580 USD
CY2019 us-gaap Gain Loss On Investments
GainLossOnInvestments
USD
CY2018 us-gaap Gain Loss On Investments
GainLossOnInvestments
4 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
729404 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
396214 USD
CY2019 sgbx Loss Debt Conversion
LossDebtConversion
52039 USD
CY2018 sgbx Loss Debt Conversion
LossDebtConversion
USD
CY2019 sgbx Loss On Equity Affilaties
LossOnEquityAffilaties
USD
CY2018 sgbx Loss On Equity Affilaties
LossOnEquityAffilaties
3626 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-699141 USD
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-448969 USD
CY2019 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-154310 USD
CY2018 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
199150 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-912749 USD
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
802797 USD
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-301457 USD
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
476127 USD
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1165930 USD
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-338161 USD
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-203926 USD
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2815621 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3452234 USD
CY2019 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
USD
CY2018 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
30037 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2070 USD
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
71306 USD
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
USD
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
5300 USD
CY2019 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
USD
CY2018 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
3626 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2070 USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50195 USD
CY2019 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
3253962 USD
CY2018 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
USD
CY2019 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
375000 USD
CY2018 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
USD
CY2019 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
480770 USD
CY2018 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
USD
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
73225 USD
CY2018 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3074967 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
USD
CY2019 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
257276 USD
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3502429 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1368395 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4870824 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1625671 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1368395 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
105770 USD
CY2018 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2019 us-gaap Stock Issued1
StockIssued1
217256 USD
CY2018 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1625671 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
17600000 USD
sgbx Proceeds From Public Offering
ProceedsFromPublicOffering
1136014 USD
CY2019Q4 sgbx Proceeds From Public Offering
ProceedsFromPublicOffering
326000000000 USD
CY2019 sgbx Proceeds From Public Offering
ProceedsFromPublicOffering
2117948000000 USD
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div> <div> <p style="color: #000000; font: 10pt 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0pt 0px 0pt 0.5in;"><span style="color: black;"><b><i>Accounting estimates<span> </span></i></b>– The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Significant areas that require the Company to make estimates include revenue recognition, stock-based compensation, warrant liabilities and allowance for doubtful accounts. Actual results could differ from those estimates.</span></p> </div> </div>
CY2019 us-gaap Operating Cycle
OperatingCycle
The length of the Company’s contracts varies, but is typically between six to twelve months.
CY2019 sgbx Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1 pure
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8190712 USD
CY2018 sgbx Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1 pure
CY2019 sgbx Warranty Offered On Completed Contracts
WarrantyOfferedOnCompletedContracts
P1Y
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2984835 USD
CY2019 sgbx License Consideration Description
LicenseConsiderationDescription
In consideration for the License, during the initial term, the Licensee agreed to pay the Company a royalty of (x) <span style="border-left: none; border-right: none;">five</span> percent (<span style="border-left: none; border-right: none;">5</span>%) on the first $<span style="border-left: none; border-right: none;">20,000,000</span> of gross revenues derived from the Licensee’s commercialization of the License (net of customary discounts, sales taxes, delivery charges, and amounts for returns) (the “Gross Revenues”), (y) <span style="border-left: none; border-right: none;">four</span> and <span style="border-left: none; border-right: none;">one</span>-half percent (<span style="border-left: none; border-right: none;">4.5</span>%) on the next $<span style="border-left: none; border-right: none;">30,000,000</span> of Gross Revenues, and (z) <span style="border-left: none; border-right: none;">five</span> percent (<span style="border-left: none; border-right: none;">5</span>%) on all Gross Revenues thereafter (collectively, the “Royalty”),
CY2019 sgbx Minimum Royalty Payments One Year
MinimumRoyaltyPaymentsOneYear
500000 USD
CY2019 sgbx Minimum Royalty Payments Two Year
MinimumRoyaltyPaymentsTwoYear
750000 USD
CY2019 sgbx Minimum Royalty Payments Three Year
MinimumRoyaltyPaymentsThreeYear
1500000 USD
CY2019 sgbx Minimum Royalty Payments Four Year
MinimumRoyaltyPaymentsFourYear
2000000 USD
CY2019 sgbx Minimum Royalty Payments Five Year
MinimumRoyaltyPaymentsFiveYear
2500000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1625671 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1368395 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
0 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
0 USD
CY2019 us-gaap Bankruptcy Proceedings Description Of Proceedings
BankruptcyProceedingsDescriptionOfProceedings
<span style="border-left: none; border-right: none;">Intangible assets consist of $<span class="ng-scope" style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">2,766,000</span></span></span> of proprietary knowledge and technology, which is being amortized over <span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">20</span></span></span></span></span> years and $<span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">1,113,000</span></span></span></span></span> of customer contracts, which is being amortized over <span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">2.5</span></span></span></span></span> years.</span> In addition, included in intangible assets is $<span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">28,820</span></span></span></span> of trademarks and <span>$<span class="ng-scope" style="border-left: none; border-right: none;"><span style="display: inline;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">5,300</span></span></span></span></span></span> of website costs that are being amortized over <span class="ng-scope" style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">5</span></span></span> years.
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1614315 USD
CY2019 us-gaap Adjustment For Amortization
AdjustmentForAmortization
145124 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1469191 USD
CY2018 us-gaap Adjustment For Amortization
AdjustmentForAmortization
589619 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
145124 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
145124 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
140800 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
139007 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
138300 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1590450 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2298805 USD
CY2018Q4 sgbx Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-1074562 USD
CY2018Q4 sgbx Estimated Income Loss On Uncompleted Contracts
EstimatedIncomeLossOnUncompletedContracts
-838615 USD
CY2019Q4 us-gaap Contract Receivable Retainage
ContractReceivableRetainage
640590 USD
CY2018Q4 us-gaap Contract Receivable Retainage
ContractReceivableRetainage
12146590 USD
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">–</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any significant credit risk on the account.</span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span class="ng-scope" style="font-family: 'Times New Roman'; font-size: 10pt;">With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At December 31, 2019 and 2018, 92% and <span class="ng-scope" style="border-left: none; border-right: none;">76</span>%, respectively, of the Company’s gross accounts receivable were due from <span style="border-left: none; border-right: none;">one</span> and <span style="border-left: none; border-right: none;">two</span> customers. </span></p> <p style="margin: 0pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span class="ng-scope" style="font-family: 'Times New Roman'; font-size: 10pt;">Revenue relating to two and three customers represented approximately 78% and 66% of the Company’s total revenue for the years ended December 31, 2019 and 2018, respectively.</span></p> <p style="margin: 0pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span class="ng-scope" style="font-family: 'Times New Roman'; font-size: 10pt;"><span class="ng-scope" style="/* background-color: #ffffff;">Cost of revenue relating to <span style="border-left: none; border-right: none;">three</span> and <span style="border-left: none; border-right: none;">two</span> </span>vendors represented approximately 74% and 55% of the Company’s total cost of revenue for the years ended December 31, 2019 and 2018, respectively. The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers.</span></p>
CY2019 sgbx Number Of Customers
NumberOfCustomers
1 Customer
CY2018 sgbx Number Of Customers
NumberOfCustomers
2 Customer
CY2019Q4 sgbx Costs In Excess Of Billings To Date
CostsInExcessOfBillingsToDate
-703532 USD
CY2018Q4 sgbx Costs In Excess Of Billings To Date
CostsInExcessOfBillingsToDate
-13221152 USD
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1887080 USD
CY2018Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2586221 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
785895 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
839895 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1101185 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1746326 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
785895 USD
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-54000 USD
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
810580 USD
CY2018 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4920 USD
CY2019Q4 sgbx Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
513558 USD
CY2018Q4 sgbx Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
11307975 USD
CY2019Q4 sgbx Estimated Income Loss On Uncompleted Contracts
EstimatedIncomeLossOnUncompletedContracts
-127032 USD
CY2019Q4 sgbx Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-62942 USD
CY2018Q4 sgbx Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-1074562 USD
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
106015 USD
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
260325 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
168957 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1334887 USD
CY2019Q4 sgbx Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-62942 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31335 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11747 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71337 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20747 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
102672 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-828472 USD
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
94031 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
564363 USD
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-449796 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-264109 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-355765 USD
CY2019 sgbx Provision Income Tax Expense Benefit
ProvisionIncomeTaxExpenseBenefit
-264109 USD
CY2018 sgbx Provision Income Tax Expense Benefit
ProvisionIncomeTaxExpenseBenefit
-355765 USD
CY2019 sgbx Amount Of Valuation Reserve
AmountOfValuationReserve
-264109 USD
CY2018 sgbx Amount Of Valuation Reserve
AmountOfValuationReserve
-355765 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2019 sgbx Differences Attributable To Change In State Business Apportionment
DifferencesAttributableToChangeInStateBusinessApportionment
-0.112 pure
CY2018 sgbx Differences Attributable To Change In State Business Apportionment
DifferencesAttributableToChangeInStateBusinessApportionment
pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.018 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.284 pure
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.011 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.074 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
-0.091 pure
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2857456 USD
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2786519 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
173840 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
238194 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
445799 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
364699 USD
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
-502709 USD
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
-684722 USD
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-850 USD
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-2548 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
82628 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
89861 USD
CY2019Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
181 USD
CY2018Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
233 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3056345 USD
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2792236 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3056345 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2792236 USD
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
264109 USD
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-355765 USD
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
12.9 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2083 shares
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2018Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
97657379 USD
CY2017Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
76659029 USD
CY2019 sgbx New Contracts Received During Year
NewContractsReceivedDuringYear
17659053 USD
CY2019 sgbx Adjustments And Cancellations Net
AdjustmentsAndCancellationsNet
-94697336 USD
CY2018 sgbx Adjustments And Cancellations Net
AdjustmentsAndCancellationsNet
-29616815 USD
CY2019 sgbx Construction Backlog Gross
ConstructionBacklogGross
20619096 USD
CY2018 sgbx Construction Backlog Gross
ConstructionBacklogGross
105848091 USD
CY2019 sgbx Contract Revenue
ContractRevenue
2984835 USD
CY2018 sgbx Contract Revenue
ContractRevenue
8190712 USD
CY2019Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
17634261 USD
CY2018Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
97657379 USD
CY2019 sgbx Number Of Large Contracts
NumberOfLargeContracts
1 Item
CY2019 sgbx Construction Backlog Contract Revenue
ConstructionBacklogContractRevenue
17 USD
CY2019Q3 sgbx Number Of Large Contracts
NumberOfLargeContracts
2 Item
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
17634261 USD
CY2017Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
100.00
CY2017Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
176771 USD
CY2017Q3 sgbx Warrants To Purchase Of Common Stock
WarrantsToPurchaseOfCommonStock
563 shares
CY2017Q3 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
8321 shares
CY2017Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
857500 shares
CY2019 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
2117948 USD
CY2019Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4239 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2019Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
45000 shares
CY2019Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
17.00
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
396214 USD
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.257 pure
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0256 pure
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
44420 shares
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
24.60
CY2017Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
77.20
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y1M24D
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1881869 USD
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
12500 shares
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.60
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
92.20
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2018 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
CY2018 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1667 shares
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
55253 shares
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
24.80
CY2018Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
81.20
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M28D
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2019 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
CY2019 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
CY2019Q4 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
24.80
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
81.20
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y4M20D
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
53170 shares
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
24.80
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
81.20
CY2019 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm
P7Y4M24D
CY2019Q4 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value One
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOne
USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
47468 shares
CY2018Q4 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
24.60
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
80.00
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y3M18D
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
52649 shares
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
150580 USD
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
332662 USD
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
13334 USD
CY2019 sgbx Share Based Non Vested Stock Options Weighted Average Term One
ShareBasedNonVestedStockOptionsWeightedAverageTermOne
P1Y3M
CY2019Q4 us-gaap Share Price
SharePrice
3.14
CY2018Q1 sgbx Number Of Employees
NumberOfEmployees
6 Employee
CY2018Q1 sgbx Options Vested Description
OptionsVestedDescription
These options vest in equal quarterly installments over either a <span class="ng-scope" style="border-left: none; border-right: none;">two</span>-year and <span class="ng-scope" style="border-left: none; border-right: none;">three</span>-year period and will fully vest by the end of March 31, 2021.
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
320000 USD
CY2019Q1 sgbx Number Of Employees
NumberOfEmployees
6 Employee
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
Restricted stock units granted to Mr. Galvin, Mr. Armstrong, Mr. Shetty, and an aggregate of <span style="border-left: none; border-right: none;">six</span> employees and <span style="border-left: none; border-right: none;">one</span> consultant of <span style="border-left: none; border-right: none;">6,139</span><span style="color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Times New Roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">, <span style="border-left: none; border-right: none;">772</span></span><span style="color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Times New Roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">, <span style="border-left: none; border-right: none;">5,729</span></span><span style="color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Times New Roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> and an aggregate of <span style="border-left: none; border-right: none;">3,063</span></span>, respectively, vest in installments over either a <span style="border-left: none; border-right: none;">one</span>-year, <span style="border-left: none; border-right: none;">two</span>-year, <span style="border-left: none; border-right: none;">three</span>-year and <span style="border-left: none; border-right: none;">four</span>-year period and will fully vest by the end of December 31, 2022. The fair value of these units upon issuance amounted to $<span style="border-left: none; border-right: none;">847,957</span>.
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Other Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOtherDescription
total of <span style="border-left: none; border-right: none;">526</span> of restricted stock units were granted to <span style="display: inline;">two</span> of the Company’s non-employee directors, under the Incentive Plan, at the calculated fair value of $<span style="border-left: none; border-right: none;">58.80</span> and $<span style="border-left: none; border-right: none;">55.20</span> per share, respectively, which represents the average closing price of the Company’s common stock for the <span style="display: inline;">ten</span> trading days immediately preceding and<span style="color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </span>including the grant date.
CY2019Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
9189 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
16.40
CY2019Q2 sgbx Description Of Alleged Unpaid Fees
DescriptionOfAllegedUnpaidFees
The complaint seeks in excess of $<span style="border-left: none; border-right: none;">1,275,754</span> in damages. EDI International, PC, filed a cross-complaint for alleged unpaid fees and tortious interference with EDI International, PC's contractual relationship with HOLA Community Partners and Heart of Los Angeles Youth, Inc. EDI International, PC's cross-complaint seeks in excess of $<span style="border-left: none; border-right: none;">30,428.71</span> in damages.
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares

Files In Submission

Name View Source Status
0001213900-20-008003-index-headers.html Edgar Link pending
0001213900-20-008003-index.html Edgar Link pending
0001213900-20-008003.txt Edgar Link pending
0001213900-20-008003-xbrl.zip Edgar Link pending
ex211_2.htm Edgar Link pending
ex231_3.htm Edgar Link pending
ex311_4.htm Edgar Link pending
ex312_5.htm Edgar Link pending
ex321_6.htm Edgar Link pending
ex413_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sgbx-20191231.htm Edgar Link pending
sgbx-20191231.xsd Edgar Link pending
sgbx-20191231_cal.xml Edgar Link unprocessable
sgbx-20191231_def.xml Edgar Link unprocessable
sgbx-20191231_htm.xml Edgar Link completed
sgbx-20191231_lab.xml Edgar Link unprocessable
sgbx-20191231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending